Method for purification of retinal pigment epithelial cells

Inventors

SAWADA, MasanoriSekiguchi, Kiyotoshi

Assignees

Healios KKUniversity of Osaka NUC

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-11492593-B2

Patent

Publication Date

2022-11-08

Expiration Date


Abstract

The present invention provides a method of purifying highly pure retinal pigment epithelial cells from a cell population obtained by induction of differentiation of pluripotent stem cells into retinal pigment epithelial cells, by a simple and easy operation in a short period. The purification method of the present invention includes a step of introducing a cell population containing retinal pigment epithelial cells obtained by differentiation induction of pluripotent stem cells on laminin or a fragment thereof on a filter, and obtaining a cell population that passed the filter.

Core Innovation

The invention relates to purifying and producing retinal pigment epithelial cells from pluripotent stem cells by inducing differentiation on a laminin-511E8 fragment. The cell population contains retinal pigment epithelial cells without forming a mixture with a jelly-like substance, and also contains other visual cells contained in the jelly-like substance.

The method recovers the entire differentiated cell population by treating it with a cell separating solution. The method dissociates adhesion between retinal pigment epithelial cells contained in the entire cell population, and then introduces the entire cell population onto a filter to obtain retinal pigment epithelial cells that pass the filter.

The filter pore size is 15-100 μm. The document states that purity and yield are improved, and that downstream production of retinal pigment epithelial cells and a retinal pigment epithelial cell sheet is enabled for therapeutic and drug-evaluation uses.

Claims Coverage

The document contains two independent claims. Both independent claims share a common multi-step inventive concept: inducing differentiation on a laminin-511E8 fragment, obtaining a recovered cell population that avoids mixture with a jelly-like substance, treating with a cell separating solution, dissociating adhesion, and filtering with a defined filter pore size range of 15-100 μm.

Differentiation on laminin-511E8 fragment to obtain a jelly-like mixture-free RPE cell population

Inducing differentiation of pluripotent stem cells into a cell population on laminin-511E8 fragment, wherein the cell population contains retinal pigment epithelial cells without forming a mixture with a jelly-like substance and other visual cells contained in the jelly-like substance.

Recovery by treating with a cell separating solution

Recovering the entire cell population obtained in the differentiation step by treating it with a cell separating solution.

Dissociating adhesion between retinal pigment epithelial cells

Dissociating adhesion between retinal pigment epithelial cells contained in the entire cell population obtained after treating with a cell separating solution.

Filtering with a defined pore size range to obtain cells that pass

Introducing the entire cell population obtained after dissociating adhesion on a filter to obtain retinal pigment epithelial cells that passed the filter, wherein the filter has a pore size of 15-100 μm.

Producing retinal pigment epithelial cells using the same purification workflow

Inducing differentiation of pluripotent stem cells into a cell population on laminin-511E8 fragment; recovering the entire cell population by treating with a cell separating solution; dissociating adhesion between retinal pigment epithelial cells; and introducing the entire cell population on a filter to obtain retinal pigment epithelial cells that passed the filter, wherein the filter has a pore size of 15-100 μm.

Across both independent claims, the inventive coverage centers on differentiating pluripotent stem cells on a laminin-511E8 fragment to obtain a cell population defined by the absence of an RPE/jelly-like mixture, followed by recovering with a cell separating solution, dissociating adhesion, and filtering with a 15-100 μm pore size to obtain retinal pigment epithelial cells that pass the filter.

Stated Advantages

Improvement of differentiation/purity yield of retinal pigment epithelial cells.

Purification purity of about 80-95% and higher purity after re-filtration/amplification.

Documented Applications

Downstream production of retinal pigment epithelial cells/sheets for retinal disease transplantation therapy.

Downstream production of retinal pigment epithelial cells/sheets for drug-evaluation uses.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.